What this trial studies
This study was conducted to examine the effect of an education program based on the Information-Motivation-Behavioral Skills (IMB) Model on the level of hot flashes, overall menopausal symptoms, and quality of life in women experiencing hot flashes during the menopausal period. The study consisted of an intervention group and a control group. The intervention group received a structured education program based on the IMB Model, while no education, counseling, or care intervention was provided to the control group. Both groups were assessed at baseline, and at the 1st and 3rd months following the intervention.
Conditions in scope
- Menopausal Hot Flashes
Interventions
- IMB Model-Based Education Program (Behavioral) — A structured education program based on the Information-Motivation-Behavioral Skills (IMB) model was delivered to women experiencing hot flashes during menopause. The intervention aimed to enhance participants' knowledge, motivation, and behavioral skills related to the management of menopausal hot flashes. The…
Who can join
Women only · Ages 44 Years to 60 Years
Inclusion criteria
- Women in the perimenopausal or postmenopausal period.
- A score of ≥ 10 on the Menopause-Specific Hot Flash Scale.
- No diagnosis of severe chronic disease and no regular medication use related to such conditions.
- Not receiving Hormone Replacement Therapy (HRT).
- No diagnosed mental disorder requiring medical treatment.
- Able to read, write, speak, and understand Turkish, with no language barriers.
- Willingness to participate in the study and provision of voluntary informed consent.
Exclusion criteria
- Initiation of Hormone Replacement Therapy during the study period.
- Refusal to participate in the study.
- Occurrence of an unexpected acute illness during the study period.
- Withdrawal from the study at any stage by personal choice.
- Incomplete completion of study questionnaires or forms after enrollment.
Eligibility wording paraphrased from the public record. View the full criteria on ClinicalTrials.gov before contacting a site.
Where it’s happening
| City | State / Region | Facility | Site status |
|---|---|---|---|
| Sivas | Sivas | Cumhuriyet University Health Services Application and Research Hospital, Obstetrics and Gynecology Outpatient Clinic | Unknown |
Status & timeline
- Overall status: Active, not recruiting
- Study type: Interventional
- Phase: N/A
- Start date: 2024-02-07
- Primary completion: 2024-11-01
- Last update posted: 2026-02-12
- First posted: 2026-02-12
Sponsor & contact
Lead sponsor: Marmara University (Other)
For trial site contact information, use the official record at ClinicalTrials.gov. Contact details change frequently and the public record is the source of truth.
Outcome measures
Primary outcomes
- Hot Flash-Related Daily Interference (Baseline (pre-intervention), 1 month, and 3 months)
Hot flash-related daily interference was assessed using the Hot Flash Related Daily Interference Scale, which evaluates the extent to which hot flashes interfere with daily activities and quality of life.
Related ClearedRx care
If you’re reading this trial because you have menopause symptoms now, you don’t have to wait for a trial to access evidence-based care. ClearedRx prescribes the same FDA-approved and compounded HRT products that have been studied in trials like this one for decades.
Important. Information from ClinicalTrials.gov as of May 8, 2026. Trial details (status, sites, contacts, eligibility, outcomes) change frequently — always check the official record at https://clinicaltrials.gov/study/NCT07407907 before contacting a site.
ClearedRx is not affiliated with this trial or its sponsor. We index public-domain ClinicalTrials.gov records to help patients find evidence-based context for menopause care decisions. ClearedRx itself is a telehealth menopause/HRT brand — we do not enroll patients in trials.